INS and obesity disorder: Interestingly, CAR activation has been shown to improve insulin sensitivity, glucose metabolism, and hepatic lipid accumulation in leptin-deficient ob/ob mice (143), and to prevent obesity, insulin resistance, and hepatic steatosis in HFD-fed mice (144).